CL
Cristian Luput
Director

Cristian Luput insider trades: MAIA Biotechnology (MAIA) stock purchases

Director, MAIA Biotechnology Last trade Nov 28, 2025 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$52K
Bought, last 12 months
2 buys
14
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Cristian reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 28, 2025MAIA↑ Buy$42K
Nov 25, 2025MAIA↑ Buy$10K
Nov 1, 2024MAIA↑ Buy$56K
Mar 14, 2024MAIA↑ Buy$81K
May 15, 2023MAIA↑ Buy10b5-1$8K
Apr 17, 2023MAIA↑ Buy10b5-1$6K
Apr 14, 2023MAIA↑ Buy10b5-1$5K
Mar 13, 2023MAIA↑ Buy10b5-1$34K
Mar 9, 2023MAIA↑ Buy10b5-1$11K
Mar 7, 2023MAIA↑ Buy10b5-1$9K
Feb 17, 2023MAIA↑ Buy10b5-1$569
Feb 15, 2023MAIA↑ Buy10b5-1$102
Jan 13, 2023MAIA↑ Buy10b5-1$2K
Aug 1, 2022MAIA↑ Buy$3K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MAIA insiders

Open-market trades in the last 12 months

About Cristian Luput's insider trades

Cristian Luput is a director at MAIA Biotechnology (MAIA). Since Aug 1, 2022, Cristian has reported 14 open-market purchases worth $266K and no sales on SEC Form 4. In the last 12 months: 2 buys ($52K).

Their filings also include grants and awards (15 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MAIA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.